healthcare News
DaVita shares climb 1.7% on earnings beat, strong 2026 outlook
Dialysis provider projects 33% EPS growth and continues aggressive share buybacks
CorMedix authorizes $75M buyback after January stock plunge
Biopharmaceutical company launches repurchase program representing 12.3% of market cap, signaling confidence at depressed valuations
Revvity beats earnings forecasts, raises outlook on diagnostics strength
Healthcare technology company posts $772 million in fourth-quarter revenue and projects FY2026 EPS growth to $5.35-$5.45
Obesity drug shares face pressure as AstraZeneca enters market
AstraZeneca's $4.7B deal with China's CSPC targets once-monthly dosing to challenge LLY/NVO duopoly
AstraZeneca bets $18.5B on obesity drugs with China's CSPC
Pharmaceutical giant pays $1.2 billion upfront for once-monthly GLP-1 treatments in race to catch Novo Nordisk and Eli Lilly
Lexicon shares fall 20% after $94.6M discounted equity offering
Biotech prices shares at $1.30, 9.7% below market, adding roughly 39 million new shares to existing float
Moderna surges on Recordati deal for rare disease therapy
Strategic partnership expands mRNA technology beyond COVID vaccines into metabolic disorders
Regenxbio director shows confidence amid FDA clinical hold
Insider exercise of 225,000 options follows 35% premarket plunge after tumor detection in gene therapy trial